121 related articles for article (PubMed ID: 26403512)
41. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer.
Yang SH; Guo JC; Yeh KH; Tien YW; Cheng AL; Kuo SH
J Gastroenterol Hepatol; 2016 Dec; 31(12):2004-2012. PubMed ID: 27059987
[TBL] [Abstract][Full Text] [Related]
42. [The prognostic value of time parameters in adjuvant radiotherapy of head and neck cancer. A retrospective analysis of 138 patients].
Dietl B; Schäfer C; Kölbl O
Strahlenther Onkol; 2005 Dec; 181(12):800-7; discussion 808-9. PubMed ID: 16362791
[TBL] [Abstract][Full Text] [Related]
43. Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients.
Su NW; Liu CJ; Leu YS; Lee JC; Chen YJ; Chang YF
Onco Targets Ther; 2015; 8():251-8. PubMed ID: 25670907
[TBL] [Abstract][Full Text] [Related]
44. Pretherapeutic nutritional/inflammatory factors as predictors for survival of both early and advanced staged head and neck cancer patients.
Yamahara K; Mizukoshi A; Lee K; Ikegami S
Auris Nasus Larynx; 2021 Aug; 48(4):731-737. PubMed ID: 33261982
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer.
Tham T; Olson C; Wotman M; Teegala S; Khaymovich J; Coury J; Costantino P
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2869-2878. PubMed ID: 30251123
[TBL] [Abstract][Full Text] [Related]
46. Survival of patients with head and neck cancer. Impact of physical status and comorbidities.
Sadat F; Wienke A; Dunst J; Kuhnt T
Strahlenther Onkol; 2012 Jan; 188(1):62-70. PubMed ID: 22189439
[TBL] [Abstract][Full Text] [Related]
47. The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England.
Lin DJ; McConkey CC; Nankivell P; Dunn J; Mehanna H
Oral Oncol; 2018 Oct; 85():40-43. PubMed ID: 30220318
[TBL] [Abstract][Full Text] [Related]
48. Pretreatment nutritional risk as a prognostic factor in head and neck cancer patients receiving radiotherapy or chemoradiotherapy.
Liu W; Gao L; Huang X; Luo J; Zhang S; Wang K; Qu Y; Xiao J; Xu G; Li Y; Yi J
Asia Pac J Clin Nutr; 2019; 28(2):223-229. PubMed ID: 31192550
[TBL] [Abstract][Full Text] [Related]
49. Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy.
Zapata I; Alvarez M; Hidalgo R; Pajares B; Garcia-Anaya MJ; Toledo MD; Trigo JM; Lupiañez-Perez Y; Medina JA; Jaime Gomez-Millan J
BMC Cancer; 2019 Dec; 19(1):1241. PubMed ID: 31864338
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.
Nordsmark M; Bentzen SM; Rudat V; Brizel D; Lartigau E; Stadler P; Becker A; Adam M; Molls M; Dunst J; Terris DJ; Overgaard J
Radiother Oncol; 2005 Oct; 77(1):18-24. PubMed ID: 16098619
[TBL] [Abstract][Full Text] [Related]
51. Reformed smokers have survival benefits after head and neck cancer.
Cao W; Liu Z; Gokavarapu S; Chen Y; Yang R; Ji T
Br J Oral Maxillofac Surg; 2016 Sep; 54(7):818-25. PubMed ID: 27364312
[TBL] [Abstract][Full Text] [Related]
52. Determining Malnutrition Assessment Criteria to Predict One-Year Mortality for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.
Ling HH; Yeh KY; Ng SH; Wang CH; Lai CH; Wu TH; Chang PH; Chou WC; Chen FP; Lin YC
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245095
[TBL] [Abstract][Full Text] [Related]
53. [New aspects of primary radiochemotherapy in head and neck cancer. Highlights from the 2011 ASCO Congress].
Laban S; Wang CJ; Knecht R; Tribius S; Münscher A
HNO; 2012 May; 60(5):393-7. PubMed ID: 22570002
[TBL] [Abstract][Full Text] [Related]
54. Determinants of long-term survival in a population-based cohort study of patients with head and neck cancer from Scotland.
Ingarfield K; McMahon AD; Douglas CM; Savage SA; Conway DI; MacKenzie K
Head Neck; 2019 Jun; 41(6):1908-1917. PubMed ID: 30620423
[TBL] [Abstract][Full Text] [Related]
55. Factors that Influence 2-Year Progression-Free Survival Among Head and Neck Cancer Patients.
Irawan C; Benbella LG; Rachman A; Mansjoer A
J Epidemiol Glob Health; 2022 Mar; 12(1):16-24. PubMed ID: 34846716
[TBL] [Abstract][Full Text] [Related]
56. The occurrence and pattern of head and neck sarcomas: a comprehensive cancer center experience.
Moreira DGL; da Silva LP; de Morais EF; Queiroz SIML; de Moura Santos E; de Souza LB; de Almeida Freitas R
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1473-1480. PubMed ID: 32020312
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for primary site necrosis after definitive concurrent chemoradiotherapy in head and neck cancer.
Kim D; Ki Y; Kim W; Park D; Joo J; Jeon H; Lee K; Nam J
Tumori; 2023 Feb; 109(1):54-60. PubMed ID: 34806477
[TBL] [Abstract][Full Text] [Related]
58. Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
Zimmaro LA; Sephton SE; Siwik CJ; Phillips KM; Rebholz WN; Kraemer HC; Giese-Davis J; Wilson L; Bumpous JM; Cash ED
Cancer; 2018 Mar; 124(5):1053-1060. PubMed ID: 29355901
[TBL] [Abstract][Full Text] [Related]
59. Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).
Matsuzuka T; Kiyota N; Mizusawa J; Akimoto T; Fujii M; Hasegawa Y; Iwae S; Monden N; Matsuura K; Onozawa Y; Hayashi R; Tahara M;
Jpn J Clin Oncol; 2019 Jan; 49(1):37-41. PubMed ID: 30364985
[TBL] [Abstract][Full Text] [Related]
60. The Role of Prognostic Factors in Salivary Gland Tumors Treated by Surgery and Adjuvant Radio- or Chemoradiotherapy - A Single Institution Experience.
Kordzińska-Cisek I; Cisek P; Grzybowska-Szatkowska L
Cancer Manag Res; 2020; 12():1047-1067. PubMed ID: 32104086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
